Monographs: Dosage forms: Specific monographs: Niclosamide tablets (Niclosamidi compressi)

Category. Anthelmintic drug.

Labelling. The designation on the container should state that the tablets should be chewed thoroughly before being swallowed.

Additional information. Strength in the current WHO Model list of essential medicines: 500 mg.

Chewable Niclosamide tablets may contain sweetening and flavouring agents.

Requirements

Comply with the monograph for Tablets.

Niclosamide tablets contain not less than 95.0% and not more than 105.0% of the amount of C13H8Cl2N2O4 stated on the label.

Identity tests

Heat a quantity of the powdered tablets equivalent to 0.5 g of Niclosamide with 25 mL of ethanol (~750 g/L) TS, filter while hot and evaporate to dryness on a water-bath. Dry the residue at 100–105 °C for 4 h.

  • The residue complies either with test A alone or with tests B, C and D.

A. Carry out the examination with the residue as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from niclosamide RS, which has been dried at 100–105 °C for 4 h, or with the reference spectrum of niclosamide.

B. Using a small flame heat 0.05 g of the residue in a test-tube. Collect and dissolve the sublimate in 5 mL of water and add a few drops of ferric chloride (25 g/L) TS; a violet colour is produced.

C. To 0.05 g of the residue add 5 mL of hydrochloric acid (1 mol/L) VS and 0.1 g of zinc R powder and heat in a water-bath for 10 minutes. Cool and filter. To the filtrate add 0.5 mL of sodium nitrite (10 g/L) TS and allow to stand for 10 minutes. Add 2 mL of ammonium sulfamate (25 g/L) TS, shake, allow to stand for 10 minutes and add 2 mL of N-(1-naphthyl)ethylenediamine hydrochloride (5 g/L) TS; a deep red colour is produced.

D. Dissolve 0.1 g of the residue in 1 mL of acetic anhydride R and boil for 10 minutes. Cool and add 10 mL of water. Collect the precipitate on a filter, wash with water, recrystallize from ethanol (~750 g/L) TS and dry at 105 °C; melting temperature of the acetyl derivative, about 178 °C.

2-Chloro-4-nitroaniline. To a quantity of the powdered tablets equivalent to 0.1 g of Niclosamide add 20 mL of methanol R and boil for 2 minutes. Cool, add sufficient hydrochloric acid (1 mol/L) VS to produce 50 mL and filter. To 10 mL of the filtrate add 1 mL of sodium nitrite (1 g/L) TS and allow to stand for 10 minutes. Add 1 mL of ammonium sulfamate (25 g/L) TS, shake, allow to stand for 10 minutes and add 1 mL of N-(1-naphthyl)ethylenediamine hydrochloride (5 g/L) TS; the colour produced is not more intense than that produced by a similarly and simultaneously treated solution containing 10 μg of 2-chloro-4-nitroaniline R.

5-Chlorosalicylic acid. To a quantity of the powdered tablets equivalent to 0.5 g of Niclosamide add 10 mL of water and boil. Cool, filter and add to the filtrate a few drops of ferric chloride (25 g/L) TS; no red or violet colour is produced.

Assay

Weigh and powder 20 tablets. To a quantity of the powder equivalent to about 0.3 g of Niclosamide, accurately weighed, add 60 mL of dimethylformamide R and titrate with tetrabutylammonium hydroxide (0.1 mol/L) VS, determining the end-point potentiometrically as described under 2.6 Non-aqueous titration, Method B.

Each mL of tetrabutylammonium hydroxide (0.1 mol/L) VS is equivalent to 32.71 mg of C13H8Cl2N2O4.

to previous sectionto next section